Related Experiment Video
Updated: Jan 21, 2026
08:38
Application of Flow Vermimetry for Quantification and Analysis of the Caenorhabditis elegans Gut Microbiome
Published on: March 31, 2023
1.1K
Prescribed Drugs and the Microbiome
1Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Visionsgatan 4, Stockholm 17177, Sweden; Science for Life Laboratory, Tomtebodavägen 23a, Stockholm 171 65, Sweden.
Gastroenterology Clinics of North America
|August 7, 2019
Summary
Drug use impacts the gut microbiome and host health. These complex interactions influence drug effectiveness, toxicity, and potential long-term side effects, explaining individual health variations.
Area of Science:
- Microbiome research
- Pharmacology
- Host-microbe interactions
Background:
- The interplay between drug consumption, the host's microbiome, and overall health is intricate.
- Both pharmaceutical compounds and microbial communities can act as either detrimental or beneficial agents in disease.
- Understanding these relationships is key to explaining individual differences in health outcomes.
Purpose of the Study:
- To explore the complex interactions between drug use, the microbiome, and the host.
- To investigate how these interactions influence disease risk and progression.
- To elucidate the mechanisms behind interpersonal variations in drug response and side effects.
Main Methods:
- Review of existing literature on drug-microbiome-host interactions.
- Analysis of data on drug metabolism influenced by microbial activity.
- Examination of studies correlating microbiome composition with drug efficacy and toxicity.
Main Results:
- Drug-microbiome interactions significantly affect drug efficacy and toxicity.
- Microbiota composition varies between individuals, influencing drug metabolism.
- These interactions can lead to unexpected or long-term side effects from medications.
Conclusions:
- The microbiome plays a critical role in modulating host responses to drugs.
- Interpersonal variations in microbiome composition contribute to differences in drug efficacy and toxicity.
- Further research into these interactions is essential for personalized medicine and mitigating adverse drug reactions.
Related Concept Videos
01:25Pharmacokinetics: Drug–Drug Interactions
384
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
384
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
154
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
154
01:26FDA Approved Drugs: Changes to Approved Drugs
246
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
246
01:27Factors Influencing Drug Absorption: Drug Dissolution
1.1K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.1K
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
456
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
456
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
222
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
222